Unlike other cancers, the fraction of CD4+ T cell immune infiltration in head and neck squamous cell carcinoma, liver cancer, lung adenocarcinoma, and lung squamous cell carcinoma was significantly decreased compared with other cancers. The gene discussed is CD4; the disease is squamous cell lung carcinoma.